Private Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Private Wealth Partners's REGN Position: Q3 2026 in Review
Private Wealth Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 360 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #149.
Private Wealth Partners first reported a position in REGN in Q3 2016 and has held it in 5 quarters since. The position peaked at $1.75M in Q4 2025. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Private Wealth Partners held 360 shares of Regeneron Pharmaceuticals worth $273K as of Q3 2026.
- Private Wealth Partners left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
- Regeneron Pharmaceuticals made up 0.02% of Private Wealth Partners's portfolio in Q3 2026, its #149 holding.
- Private Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 5 quarters since.
- Private Wealth Partners's Regeneron Pharmaceuticals position peaked at $1.75M in Q4 2025.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Private Wealth Partners's 13F filing for Q3 2026, filed 22 Oct 2026.